A股異動 | 莫高股份六連板 儘管澄清稱生物降解項目佔營收不足10% 一直在虧損
格隆匯8月10日丨莫高股份今日大幅低開,隨後走高至午後已觸及漲停板,報11.12元,這是該股自8月3日以來連續第六個漲停板,11.12元/股漲停價格也創下兩年半來歷史新高。近期,有消息指出,莫高股份為“預期差最大、可降解塑料產能/市值比最大、彈性最高,兼具生物基和石化基雙賽道的可降解塑料黑馬”。莫高股份在8月7日盤後表示:公司生物降解母粒及製品項目近年來持續虧損,投產運營時間和投資收益遠未達到預期;公司生物降解聚酯新材料項目目前正在建設,尚未投產運營。上述兩個項目營業收入佔莫高股份營業收入不足10%,對公司整體經營業績影響較小。預計受研發技術、市場環境等因素影響,未來收益存在不確定性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.